Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Page Not Found
Cart summary

You have no items in your shopping cart.

KO/KD Validated Antibodies

 

Select antibodies with greater confidence using Biorbyt KO/KD validated antibodies, evaluated using knockout or knockdown models to assess whether antibody signal changes with expression of the intended target. Genetic validation provides an important additional level of evidence for antibody specificity, helping distinguish target-dependent signal from non-specific background. Browse the products below or contact our technical support team for help choosing an antibody for your application.

KO/KD Validated Antibodies

What are KO/KD validated antibodies?

KO/KD validated antibodies are antibodies whose target specificity has been evaluated using samples in which expression of the target gene has been eliminated or reduced.

In knockout (KO) validation, antibody signal is compared between a knockout sample, in which the target gene has been disrupted, and an appropriate wild-type or control sample.

In knockdown (KD) validation, expression of the target is reduced rather than completely eliminated, and antibody signal is compared with the corresponding control.

Loss or reduction of the expected signal following knockout or knockdown supports the conclusion that the antibody is detecting the intended target.

When should I use a KO/KD validated antibody?

KO/KD validated antibodies are particularly useful when a high level of confidence in antibody specificity is important. Genetic validation can help determine whether the observed signal is dependent on expression of the intended target rather than non-specific antibody binding.

Consider using a KO/KD validated antibody when:

  • You need to distinguish the expected target signal from non-specific bands or background staining.
  • You are establishing a new antibody-based assay and want additional evidence supporting antibody specificity.
  • Your experiment produces unexpected bands, staining patterns or background signals that require further interpretation.
  • Reliable target identification is especially important for quantitative, mechanistic or reproducibility-focused studies.
  • You want to compare antibody performance using a genetically defined negative or reduced-expression control.

KO validation vs KD validation

Both knockout and knockdown validation assess whether antibody signal is associated with expression of the intended target. The main difference is the extent to which target expression is altered.

KO

Knockout validation

In a knockout model, the target gene is disrupted so that expression of the corresponding protein is eliminated or substantially affected.

The antibody signal in the knockout sample is compared with the corresponding wild-type sample. Disappearance of the expected signal in the KO sample provides strong evidence that the signal is target-dependent.

KD

Knockdown validation

In a knockdown model, target expression is reduced rather than completely eliminated, commonly through gene-silencing approaches.

A corresponding reduction in antibody signal relative to the control supports target-specific detection. Because residual target expression may remain, complete disappearance of the signal is not necessarily expected.

How do I choose the right KO/KD validated antibody?

KO/KD validation is an important factor when selecting an antibody, but the validation should also be relevant to your specific experimental setup.

When comparing KO/KD validated antibodies, consider:

  • Application: Check whether the antibody has been validated for the method you plan to use, such as western blot, immunofluorescence or immunohistochemistry.
  • Species and sample type: Confirm that the antibody is suitable for the species, cell line, tissue or other biological sample used in your experiment.
  • Validation method: Review whether the product was evaluated using knockout or knockdown samples and how the genetically modified sample was compared with the control.
  • Validation data: Examine the experimental images and conditions rather than relying only on the KO/KD validation designation.
  • Expected signal: For western blot, consider the expected molecular weight and band pattern. For imaging applications, review whether the observed staining pattern is consistent with the expected biology of the target.
  • Antibody format: Select the appropriate host species, clonality and conjugation format for your experimental workflow.

How should I interpret KO/KD validation data?

The key comparison is between the control sample and the corresponding KO or KD sample.

  • In a KO sample, disappearance or substantial loss of the expected signal supports target-specific detection.
  • In a KD sample, the expected signal should decrease in line with reduced target expression, although residual signal may remain.
  • Bands or staining that remain unchanged after target knockout or knockdown may represent non-specific signal and should be interpreted carefully.

KO/KD validation is application-dependent

Genetic validation provides valuable evidence supporting antibody specificity, but validation in one application does not automatically demonstrate identical performance in every experimental method, tissue or sample type. Always review the application-specific validation data and recommended experimental conditions for the individual product.

Explore Biorbyt KO/KD validated antibodies

Browse KO/KD validated antibodies for western blot, immunofluorescence, immunohistochemistry and other research applications.

View Products

Featured Products